PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ip Group Plc | LSE:IPO | London | Ordinary Share | GB00B128J450 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.45 | -2.38% | 59.40 | 59.40 | 59.75 | 64.65 | 59.35 | 64.65 | 1,087,234 | 16:35:19 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| General Financial | 0.0 | 186.1 | 17.5 | 3.4 | 614 |
Ip (IPO) News Headlines
Ip News
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/9/2022 | 10:39 | UKREG | IP Group PLC Total Voting Rights |
| 21/9/2022 | 17:29 | UKREG | IP Group PLC Holding(s) in Company |
| 20/9/2022 | 18:10 | UKREG | IP Group PLC Director/PDMR Shareholding |
| 15/9/2022 | 16:41 | RNSNON | IP Group PLC Investor presentation |
| 14/9/2022 | 16:33 | UKREG | IP Group PLC Further re Scrip Dividend |
| 13/9/2022 | 18:00 | UKREG | IP Group PLC Further re Interim Scrip Dividend |
| 07/9/2022 | 16:33 | UKREG | IP Group PLC Director/PDMR Shareholding, SAYE scheme |
| 31/8/2022 | 10:27 | ALNC |  IP Group portfolio company begins phase two trial of arthritis drug |
| 31/8/2022 | 08:51 | RNSNON | IP Group PLC Istesso starts Phase 2b trial of MBS2320 |
| 30/8/2022 | 12:59 | RNSNON | IP Group PLC Cash acquisition of portfolio company Diurnal |
1 Year Ip Chart |
Intraday Ip Chart |
